UK government launches Research Support Service backed by $118.6m funding
The UK’s National Institute for Health and Care has set aside funds to launch a new support service aimed at streamlining and encouraging research projects across England.
06 October 2023
06 October 2023
The UK’s National Institute for Health and Care has set aside funds to launch a new support service aimed at streamlining and encouraging research projects across England.
This is the second time Innate’s lacutamab development has been halted, with the first partial hold in 2020 due to manufacturing concerns.
The company is designing a less invasive treatment option for communicating hydrocephalus.
The study will compare two oral dose levels of BMF-219 against placebo control.
Real-world data of Artivion’s On-X heart valve showed reduced mortality and bleeding events with a low dose of warfarin therapy.
The study met the primary endpoint demonstrating a decrease from baseline in serum androstenedione at week four.
The RP2D will be used in the Phase II study to further validate the dose and assess the efficacy and safety of ONCT-534.
Initially, the trial intends to enrol at least six symptomatic adults with MYBPC3-associated nonobstructive HCM.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.